248. Treatment of Antimicrobial-Resistant Infections: Saturday, 12:15 - 1:30 p.m.
Poster Session: Treatment of Antimicrobial-Resistant Infections
Marya D. Zilberberg, MD, MPH
President & CEO
EviMed Research Group, LLC
Goshen, Massachusetts, United States
Brian H. Nathanson, Ph.D.
President & CEO
OptiStatim LLC
Longmeadow, Massachusetts, United States
Mark A. Redell, PharmD (he/him/his)
Vice-President, Scientific Affairs
Melinta Therapeutics
Parsippany, New Jersey, United States
Kate Sulham, MPH
Melinta Therapeutics
Parsippany, New Jersey, United States
Andrew Shorr, MD, MPH, MBA
Section Director, Pulmonary and Critical Care Medicine
Medstar Washington Hospital Center, United States